229 related articles for article (PubMed ID: 28452000)
1. Ultrasound characterization of insulin induced lipohypertrophy in type 1 diabetes mellitus.
Bertuzzi F; Meneghini E; Bruschi E; Luzi L; Nichelatti M; Epis O
J Endocrinol Invest; 2017 Oct; 40(10):1107-1113. PubMed ID: 28452000
[TBL] [Abstract][Full Text] [Related]
2. Associations of insulin-induced lipodystrophy in children, adolescents, and young adults with type 1 diabetes mellitus using recombinant human insulin: a cross-sectional study.
Singha A; Bhattacharjee R; Dalal BS; Biswas D; Choudhuri S; Chowdhury S
J Pediatr Endocrinol Metab; 2021 Apr; 34(4):503-508. PubMed ID: 33662195
[TBL] [Abstract][Full Text] [Related]
3. Subclinical lipohypertrophy--Easily ignored complications of insulin therapy.
Luo D; Shi Y; Zhu M; Wang H; Yan D; Yu J; Ji J; Liu X; Fan B; Xu Y; Zhang M; He W; Xu J; Yang T
J Diabetes Complications; 2021 Mar; 35(3):107806. PubMed ID: 33280982
[TBL] [Abstract][Full Text] [Related]
4. Values of ultrasound for diagnosis and management of insulin-induced lipohypertrophy: A prospective cohort study in China.
Wang W; Huang R; Chen Y; Tu M
Medicine (Baltimore); 2021 Jul; 100(29):e26743. PubMed ID: 34398053
[TBL] [Abstract][Full Text] [Related]
5. Relationship Between Lipohypertrophy, Glycemic Control, and Insulin Dosing: A Systematic Meta-Analysis.
Mader JK; Fornengo R; Hassoun A; Heinemann L; Kulzer B; Monica M; Nguyen T; Sieber J; Renard E; Reznik Y; Ryś P; Stożek-Tutro A; Wilmot EG
Diabetes Technol Ther; 2024 May; 26(5):351-362. PubMed ID: 38215209
[No Abstract] [Full Text] [Related]
6. Ultrasound detection of insulin-induced lipohypertrophy in Type 1 and Type 2 diabetes.
Kapeluto JE; Paty BW; Chang SD; Meneilly GS
Diabet Med; 2018 Oct; 35(10):1383-1390. PubMed ID: 29908078
[TBL] [Abstract][Full Text] [Related]
7. Lipohypertrophy and Insulin: An Update From the Diabetes Technology Society.
Tian T; Aaron RE; Huang J; Yeung AM; Svensson J; Gentile S; Forbes A; Heinemann L; Seley JJ; Kerr D; Klonoff DC
J Diabetes Sci Technol; 2023 Nov; 17(6):1711-1721. PubMed ID: 37555266
[TBL] [Abstract][Full Text] [Related]
8. Differences in depression, treatment satisfaction and injection behaviour in adults with type 1 diabetes and different degrees of lipohypertrophy.
Hernar I; Haltbakk J; Broström A
J Clin Nurs; 2017 Dec; 26(23-24):4583-4596. PubMed ID: 28295770
[TBL] [Abstract][Full Text] [Related]
9. Errors in insulin treatment management and risk of lipohypertrophy.
Pozzuoli GM; Laudato M; Barone M; Crisci F; Pozzuoli B
Acta Diabetol; 2018 Jan; 55(1):67-73. PubMed ID: 29098390
[TBL] [Abstract][Full Text] [Related]
10. Insulin-induced lipodystrophy and interest of insulin injection ports.
Ben Abdelkrim A; Fathallah N; Omri M; Hasni Y; Khaldi S; Kacem M; Chaieb M; Ben Salem C; Maaroufi A; Ach K
Therapie; 2019 Dec; 74(6):680-682. PubMed ID: 31088690
[No Abstract] [Full Text] [Related]
11. Clinical significance of lipohypertrophy without visual and palpable changes detected by ultrasonography of subcutaneous fat.
Volkova NI; Davidenko IY
Ter Arkh; 2019 May; 91(4):62-66. PubMed ID: 31094478
[TBL] [Abstract][Full Text] [Related]
12. Lipohypertrophy in China: Prevalence, Risk Factors, Insulin Consumption, and Clinical Impact.
Ji L; Sun Z; Li Q; Qin G; Wei Z; Liu J; Chandran AB; Hirsch LJ
Diabetes Technol Ther; 2017 Jan; 19(1):61-67. PubMed ID: 28099050
[TBL] [Abstract][Full Text] [Related]
13. Effect of Insulin-Induced Lipodystrophy on Glycemic Control among Children and Adolescents with Diabetes in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.
Tsadik AG; Atey TM; Nedi T; Fantahun B; Feyissa M
J Diabetes Res; 2018; 2018():4910962. PubMed ID: 30116742
[TBL] [Abstract][Full Text] [Related]
14. Insulin Injection Into Lipohypertrophic Tissue: Blunted and More Variable Insulin Absorption and Action and Impaired Postprandial Glucose Control.
Famulla S; Hövelmann U; Fischer A; Coester HV; Hermanski L; Kaltheuner M; Kaltheuner L; Heinemann L; Heise T; Hirsch L
Diabetes Care; 2016 Sep; 39(9):1486-92. PubMed ID: 27411698
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factors.
Hauner H; Stockamp B; Haastert B
Exp Clin Endocrinol Diabetes; 1996; 104(2):106-10. PubMed ID: 8740933
[TBL] [Abstract][Full Text] [Related]
16. Lipohypertrophy and Insulin: An Old Dog That Needs New Tricks.
Huang J; Yeung AM; Kerr D; Gentile S; Heinemann L; Al-Sofiani ME; Joseph JI; Seley JJ; Klonoff DC
Endocr Pract; 2023 Aug; 29(8):670-677. PubMed ID: 37098370
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Lipohypertrophy in Patients With Type 1 Diabetes Mellitus on Multiple Daily Insulin Injections or Continuous Subcutaneous Insulin Infusion.
Barlas T; Yalcin MM; Coskun M; Demirel D; Altinova AE; Toruner FB; Karakoc MA; Yetkin I; Akturk M
Endocr Pract; 2023 Feb; 29(2):119-126. PubMed ID: 36423861
[TBL] [Abstract][Full Text] [Related]
18. Type 1 Diabetes Mellitus and Lipohypertrophy - Impact of the Intervention on Glycemic Control via Patient's Examination and Retraining on Change of Infusion Set.
Ucieklak D; Mrozińska S; Wojnarska A; Małecki MT; Klupa T; Matejko B
Endocr Pract; 2023 Mar; 29(3):174-178. PubMed ID: 36581082
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and morphology of lipohypertrophic lesions in adults with type 1 diabetes with ultrasound screening: an exploratory observational study.
Hashem R; Mulnier H; Abu Ghazaleh H; Halson-Brown S; Duaso M; Rogers R; Karalliedde J; Forbes A
BMJ Open Diabetes Res Care; 2021 Dec; 9(2):. PubMed ID: 34876413
[TBL] [Abstract][Full Text] [Related]
20. Local complications of insulin administration sites and effect on diabetes management.
Demir G; Er E; Atik Altınok Y; Özen S; Darcan Ş; Gökşen D
J Clin Nurs; 2022 Sep; 31(17-18):2530-2538. PubMed ID: 34622517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
